Pfizer (PFE) Long-Term Deferred Tax (2009 - 2026)
Pfizer (PFE) posted quarterly Long-Term Deferred Tax of $10.0 billion for Q1 2026, up 4.43% year-over-year from $9.5 billion in Q1 2025, and up 2.74% quarter-over-quarter from $9.7 billion in Q4 2025.
Pfizer (PFE) Long-Term Deferred Tax (2009 - 2026) Analysis & Trends
Pfizer (PFE) has reported Long-Term Deferred Tax for 18 consecutive years, with $10.0 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Long-Term Deferred Tax rose 4.43% year-over-year to $10.0 billion; the TTM figure through Mar 2026 stood at $10.0 billion (up 4.43% YoY), while the FY2025 annual figure was $9.7 billion, up 11.97% from the prior year.
- Long-Term Deferred Tax advanced to $10.0 billion in Q1 2026 per PFE's latest filing, from $9.7 billion in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $17.3 billion in Q4 2023 and bottomed at $4.9 billion in Q1 2024.
- Historically, Long-Term Deferred Tax has averaged $9.3 billion across 5 years, with a median of $8.7 billion in 2024.
- Annual changes were most pronounced in 2022 — Long-Term Deferred Tax jumped 159.91% — and 2024, when it slumped 49.93%.
- Pfizer's Long-Term Deferred Tax stood at $13.3 billion in 2022, then surged by 30.41% to $17.3 billion in 2023, then slumped by 49.93% to $8.7 billion in 2024, then gained by 11.97% to $9.7 billion in 2025, then gained by 2.74% to $10.0 billion in 2026.
- Business Quant data shows PFE's Long-Term Deferred Tax at $10.0 billion in Q1 2026, $9.7 billion in Q4 2025, and $11.0 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 10.77 Bn |
| Mar 29, 2026 | 9.97 Bn |
| Dec 31, 2025 | 9.70 Bn |
| Sep 28, 2025 | 11.05 Bn |
| Jun 29, 2025 | 10.34 Bn |
| Mar 30, 2025 | 9.54 Bn |
| Dec 31, 2024 | 8.66 Bn |
| Sep 29, 2024 | 7.91 Bn |
| Jun 30, 2024 | 7.87 Bn |
| Mar 31, 2024 | 4.94 Bn |
| Dec 31, 2023 | 17.30 Bn |
| Jul 2, 2023 | 8.26 Bn |
| Apr 2, 2023 | 7.30 Bn |
| Dec 31, 2022 | 13.27 Bn |
| Jul 3, 2022 | 7.00 Bn |
| Apr 3, 2022 | 5.67 Bn |
| Dec 31, 2021 | 8.98 Bn |
| Oct 3, 2021 | 2.76 Bn |
| Jul 4, 2021 | 2.69 Bn |
| Apr 4, 2021 | 2.54 Bn |